Marimed (MRMD) Receivables - Net (2011 - 2026)

Marimed (MRMD) has reported Receivables - Net for 15 consecutive years, with $9.4 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Receivables - Net rose 21.72% year-over-year to $9.4 million in Q2 2026; TTM through Jun 2026 was $9.4 million, a 21.72% increase from a year earlier, with the FY2025 full-year figure at $9.1 million, up 1.3% from the prior year.
• Receivables - Net was $9.4 million for Q2 2026 at Marimed, down from $9.4 million in the prior quarter.
• Over five years, Receivables - Net peaked at $9.4 million in Q1 2026 and troughed at $3.5 million in Q1 2022.
• A 5-year average of $7.3 million and a median of $7.7 million in 2024 frame the typical range for Receivables - Net.
• The widest YoY moves for Receivables - Net: up 425.81% in 2022, down 52.84% in 2022.
• Over 5 years, Receivables - Net stood at $8.8 million in 2022, then fell by 9.1% to $8.0 million in 2023, then rose by 12.99% to $9.0 million in 2024, then gained by 1.3% to $9.1 million in 2025, then advanced by 2.68% to $9.4 million in 2026.
• The last three Receivables - Net figures came in at $9.4 million (Q2 2026), $9.4 million (Q1 2026), and $9.1 million (Q4 2025), per Business Quant data.